Filing Details
- Accession Number:
- 0001144204-10-027621
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-05-14 13:00:00
- Reporting Period:
- 2010-05-12
- Filing Date:
- 2010-05-14
- Accepted Time:
- 2010-05-14 17:00:36
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1114220 | Keryx Biopharmaceuticals Inc | KERX | Pharmaceutical Preparations (2834) | 134087132 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1434718 | Iii F James Oliviero | C/O Keryx Biopharmaceuticals, Inc. 750 Lexington Avenue, 20Th Floor New York NY 10022 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2010-05-12 | 31,667 | $2.14 | 470,751 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2010-05-12 | 60,000 | $6.26 | 410,751 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Footnotes
- Reflects the weighted average sale price. The range of prices for such transaction is $6.19 to $6.35.
- Of the 410,751 shares, 321,042 are shares of restricted stock.
Billionaire Hedge Funds
